Bitcoin

Bitcoin
Bitcoin

Ripple secures Luxembourg EMI licence to expand regulated EU payments

Ripple has secured full approval for an Electronic Money Institution licence in Luxembourg, a regulatory milestone that clears the way for the company to scale payments services across the European Union. The authorisation was granted by Luxembourg’s financial regulator, the Commission de Surveillance du Secteur Financier, after Ripple met all outstanding conditions tied to its

Read More
Bitcoin

XRP holds the $1.5 support despite low retail interest: check forecast

Ripple’s XRP has been one of the worst performers among the top 10 cryptocurrencies by market cap in recent weeks.  The coin is down by less than 1% in the last 24 hours and is currently trading around $1.6 per coin. XRP is attempting to recover from last week’s sharp decline that tested support at

Read More
Bitcoin

XRP could retest the $1.44 support as bearish conditions persist

Bitcoin (BTC), Ethereum (ETH), and Ripple (XRP) remain under pressure, with the leading cryptocurrencies recording losses since the start of the week. Bitcoin fell to its lowest level since early November 2024, to $72,945, following Tuesday’s selloff. ETH and XRP, following BTC’s lead, extended their losses, with Ether hitting a seven-month low while XRP retested

Read More
Bitcoin

BTC sinks below $70K, XRP plunges 14%: why the crypto market is crashing

Bitcoin fell below the $70,000 mark on Thursday, reaching its lowest level in about 15 months, as a broad risk-off sentiment swept across global financial markets and intensified pressure on digital assets. The world’s largest cryptocurrency slid as low as $69,821 in early New York trading before stabilising slightly, hovering near levels last seen around

Read More
Bitcoin

This historical pattern shows how low XRP price could go before rebounding

The post This historical pattern shows how low XRP price could go before rebounding appeared first on Invezz

Read More
Bitcoin

S&P 500, Nasdaq futures edge higher as earnings season intensifies

US futures largely gained on Tuesday ahead of the market open as investors digested a strong start to the month for US equities and prepared for a heavy slate of corporate earnings. Market sentiment was shaped by upbeat results from select technology names, volatility in commodities and crypto, and renewed focus on returns from artificial

Read More
Bitcoin

Palantir stock jumped after earnings, but a risky pattern points to a crash

Palantir stock price rebounded by over 6% in the extended hours after the software company published strong results that beat analysts’ estimates. PLTR jumped to $158, up substantially from the year-to-date low of $146. So, will it continue rising as a major risky pattern forms? Palantir published strong financial results  Palantir, the company that Alex

Read More
Bitcoin

Oil prices to trade at $55–$65 range through Q1 2026 amid persistent oversupply, demand headwinds, warns Mind Money’s Igor Isaev

With Brent crude trading in the $65–$70 corridor and a 2.3 million barrels per day (bpd) global surplus pressuring prices, Igor Isaev, Doctor of Technical Sciences and Head of Analytics at Mind Money, sees no near-term catalysts for a breakout higher.  In an exclusive interview with Invezz, Isaev discusses persistent oversupply, Venezuela’s infrastructure challenges, Iran’s

Read More
Bitcoin

PayPal shares slide 15% on forecast and earnings; company announces new CEO

PayPal reported a weaker-than-expected fourth quarter and issued a subdued profit forecast for 2026, underscoring mounting pressure from slowing consumer spending and intensifying competition in digital payments. The company said it expects full-year adjusted profit to decline in the low-single digit percentage to increase slightly, far below Wall Street expectations of roughly 8% growth, according

Read More
Bitcoin

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer reported fourth-quarter results that beat expectations, offering a steadier earnings picture as the company moves further away from the Covid-driven revenue surge of recent years. While demand for its pandemic-era products continues to fade, the pharmaceutical group is refocusing its strategy around pipeline development, targeted acquisitions, and large-scale cost reductions. The latest earnings update

Read More